CLX leans on premium innovation and smart pricing to protect market share and margins amid shifting consumer demand.

As Clorox has underperformed its broader sector recently, analysts remain cautious about the stock’s prospects.

However, Clorox faces increasing competition from private label products, which could potentially impact its market share in the long term. The company's ability to innovate and differentiate its ...

Clorox goes to bat against lower-priced private-label fare in most categories, but we think investments in innovation and marketing should help its products win at the shelf and stifle trade-down.

Kimberly-Clark's cost-saving plans aim for $200M in SG&A by 2027, boosted by global tissue market growth. Find out why KMB is ...

Pleshek, 38, shot to fame after a video of him vacuuming went viral in 2020—and he's since become TikTok's favorite cleaning ...

As for June 2025, Clorox is a $7 billion revenue business with around $1 billion in operating income. Both numbers have shrunk from 2020–21 highs of $7.4 billion and $1.25 billion, respectively.

To verify if a product is "Made in the USA," check the label for that exact wording. Beware of qualifying language like "Assembled in the USA" or "with imported parts." If you're unsure ...

Clorox: The consumer products company continues to be well-positioned ... Additionally, Grocery Outlet is accelerating the rollout of its private-label offerings to boost value and differentiation.

Dividend stocks, or shares of companies that regularly distribute a portion of profits to shareholders, offer investors a ...